ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 181 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $286,315 | +18.7% | 7,080 | +36.5% | 0.01% | -18.2% |
Q4 2022 | $241,206 | -23.9% | 5,185 | -15.2% | 0.01% | +10.0% |
Q3 2022 | $317,000 | +3.3% | 6,116 | -6.5% | 0.01% | +11.1% |
Q2 2022 | $307,000 | -28.8% | 6,544 | +5.1% | 0.01% | 0.0% |
Q1 2022 | $431,000 | -5.9% | 6,227 | +1.4% | 0.01% | 0.0% |
Q4 2021 | $458,000 | +10.6% | 6,143 | -16.8% | 0.01% | +12.5% |
Q3 2021 | $414,000 | +58.6% | 7,381 | +23.9% | 0.01% | +100.0% |
Q2 2021 | $261,000 | -12.1% | 5,957 | -3.6% | 0.00% | -20.0% |
Q1 2021 | $297,000 | -26.8% | 6,179 | -36.7% | 0.01% | -44.4% |
Q4 2020 | $406,000 | -19.4% | 9,766 | -13.1% | 0.01% | -43.8% |
Q3 2020 | $504,000 | +76.8% | 11,244 | +93.2% | 0.02% | +60.0% |
Q2 2020 | $285,000 | – | 5,820 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |